Results

Total Results: 1,027 records

Showing results for "drug".

101. Archived: Evidence Summary: NSAIDs: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
     March 15, 2007 - Nonsteroidal Anti-inflammatory Drug (NSAID) Chemoprevention of Colonic Adenomas: Included Randomized, … Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. … Pharmacoepidemiol Drug Saf 1998;7:99-106. [PMID: 15073733] 50. … Food and Drug Administration. … Arthritis & Drug Safety and Risk Management Advisory Committee Briefing Package.

102. Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/c-7ARQE9RuXKjjpeLABkaH
     March 01, 2007 - Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma. … Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. … Pharmacoepidemiol Drug Saf. 1998;7:99-106. [PMID: 15073733] 18.

103. First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services - V | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/first-annual-report-congress-high-priority-evidence-gaps-clinical-preventive-services-v
     December 01, 2011 - led to research efforts on a larger scale: A major grants initiative by the National Institute on Drug … review by the Task Force indicated that there was insufficient evidence to recommend screening for drug … The NIDA initiative provided funds for researchers to study the use of drug abuse screening in primary … Screening for Illicit Drug Use Illicit drug use and abuse is a serious problem in the United States … determine whether interventions found effective for treatment-seeking individuals with symptoms of drug

104. Archived: Hepatitis B Virus Infection: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-virus-infection-screening-1996
     January 01, 1996 - 1990, heterosexual activity accounted for 27% of cases, homosexual activity for 11%, and injection drug … inner-city pregnant women, those who presented for delivery without prenatal care, with a positive drug … screen, or with a past history of any illicit drug use were at increased risk for HbsAg positivity. … 18 For example, those with no prenatal care and positive urine drug screens were 29 times more likely … of patients have no identifiable risk factors 6 and because high-risk individuals (e.g., injection drug

105. Ztmgupsekcuuupvpegum45 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZTMgupsEkCUuuPVpeGUm45
     September 01, 2013 - The most important risk factor for HCV infection is past or current injection drug use, with most studies … use, sex with an injection drug user, or blood trans- fusion before 1992), anti-HCV antibody testing … In contrast, 60% of new HCV infections occur in persons who report injection drug use within the past … use, sex with an injection drug user, and receipt of blood transfusion before 1992. … Food and Drug Administration drug approval.

106. Screening for Osteoporosis: Clinical Summary of U.S. Preventive Services Task Force Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/gAqZddz9msR33tXRy9MtX7
     January 11, 2011 - Food and Drug Administration–approved therapies reduce fracture risk in women with low bone mineral … Clinicians should provide education about how to minimize drug side effects.

107. U.S. Preventive Services Task Force Begins Work on Opioid Use Disorder Prevention (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/opioid-use-disorder-draft-resplan-bulletin_0.pdf
     January 16, 2019 - an opioid use disorder, and opioid use was involved in nearly two-thirds of more than 70,000 fatal drug … topic, the Task Force is currently updating its 2008 recommendation statement on screening for illicit drug

108. Announcements | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/news/announcements?page=14
     August 07, 2018 - Delivery 2018-05-17 Public Comment on Draft Research Plan: Interventions to Reduce Illicit Drug … and Nonmedical Prescription Drug Use in Children and Adolescents 2018-05-10 Final Recommendation

109. Public Comment on Draft Research Plan: Interventions to Reduce the Nonmedical Use of Drugs in Children and Adolescents | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-research-plan-interventions-reduce-nonmedical-use-drugs-children-and-adolescents
     February 11, 2013 - Public Comment on Draft Research Plan: Interventions to Reduce the Nonmedical Use of Drugs in Children and Adolescents Share to Facebook Share to X Share to WhatsApp Share to Email Print January 15, 2013 – Today, the U.S. Preventive Services …

110. U.S. Preventive Services Task Force Highlights High-Priority Evidence Gaps in 2019 Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/2019-annual-report-congress-news-bulletin.pdf
     January 01, 2019 - Tobacco Use Prevention and Cessation in Children and Adolescents: Primary Care Interventions • Illicit Drug … Use, Including Nonmedical Use of Prescription Drug Use in Adolescents and Adults: Screening by Asking … About Drug Use • Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening

111. Archived: Hypertension: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/hypertension-screening-1996
     January 01, 1996 - The decision to begin drug therapy may include consideration of the level of blood pressure elevation … The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease … Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart … Drug treatment of hypertension in the elderly: a meta-analysis. … Effect of drug and diet treatment of mild hypertension on diastolic blood pressure.

112. Final Research Plan: Hepatitis B Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/hepatitis-b-virus-infection-screening
     March 14, 2019 - interest for Key Questions 4, 5, and 6 include those defined by age, race/ethnicity, sex, injection drug … of antiviral medications Withdrawals due to adverse events Serious adverse events KQ 4: Drug … Food and Drug Administration; HBeAg = hepatitis B e-antigen; HBsAg = hepatitis B surface antigen; HBV … In addition, the USPSTF added injection drug use status and nonalcoholic steatohepatitis as subgroup

113. Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/EppFbhnDEX5UtYWrTkLEhT
     March 01, 2007 - Food and Drug Administration News Digest and Health Canada’s Health Product Information mailing list … Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. … Pharmacoepidemiol Drug Saf. 1998;7:99-106. [PMID: 15073733] 50. … Food and Drug Administration. … Arthritis & Drug Safety and Risk Management Advisory Committee Briefing Package.

114. Zr66Ep5Abbqcuqy7Ktdetn (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZR66ep5ABbQCUQy7KTDETn
     July 01, 2014 - Food and Drug Administration–approved hepatitis B surface antigen (HBsAg) test followed by a licensed … Food and Drug Administration has approved 7 anti- viral drugs for treatment of chronic HBV infection: … Food and Drug Administration and are generally not used as first-line treatment because tolerability, … Several factors affect the choice of antiviral drug, in- cluding patient characteristics, HBV DNA and … High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology. 2004;39:51-7.

115. Archived: Final Evidence Summary: Lipid Disorders in Children: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary34/lipid-disorders-in-children-screening-2007
     July 15, 2007 - Trials of drug therapy in children with heterozygous FH or FCH are included because drug treatment trials … No studies evaluated drug interventions in children without monogenic dyslipidemia. … Drug treatment. … All subjects declared preference for this drug over cholestyramine. … Good quality studies with fair external validity for drug therapy.

116. Archived: Evidence Summary: Blood Pressure in Adults (Hypertension): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary15/blood-pressure-in-adults-hypertension-screening
     October 15, 2007 - reviewers extracted data from studies on the harms of early treatment, including adverse effects of drug … These studies compared outcomes from treatment of one type of drug versus another type of drug or placebo … Serious adverse effects were uncommon, and 2 of the 3 reported events were probably not related to the drug … The amlodipine group experienced symptoms commonly associated with the drug, including ankle swelling … Serious AEs were uncommon (2%-3%), and 2 of the 3 reported were probably not related to the drug.

117. Archived: Evidence Summary: Blood Pressure in Adults (Hypertension): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary15/blood-pressure-in-adults-hypertension-screening-2007
     October 15, 2007 - reviewers extracted data from studies on the harms of early treatment, including adverse effects of drug … These studies compared outcomes from treatment of one type of drug versus another type of drug or placebo … Serious adverse effects were uncommon, and 2 of the 3 reported events were probably not related to the drug … The amlodipine group experienced symptoms commonly associated with the drug, including ankle swelling … Serious AEs were uncommon (2%-3%), and 2 of the 3 reported were probably not related to the drug.

118. Evidence for the Reaffirmation of the USPSTF Recommendaiton on Screening for High Blood Pressure (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/KSYrhQuAswGjTww_4sDFGZ
     December 01, 2007 - reviewers extracted data from studies on the harms of early treatment, including adverse effects of drug … Serious AEs were uncommon (2%–3%), and 2 of the 3 reported were probably not related to the drug. … These studies compared out- comes from treatment of one type of drug versus another type of drug or placebo … Serious adverse effects were uncommon, and 2 of the 3 reported events were probably not related to the drug … The amlodipine group experienced symptoms commonly asso- ciated with the drug, including ankle swelling

119. Archived: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
     March 15, 2007 - Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. … Pharmacoepidemiol Drug Saf 1998;7:99-106. … Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma.

120. U.S. Preventive Services Task Force Issues Final Recommendation Statements on HIV Screening and HIV Prevention (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/hiv-screening-prep-final-rec-news-bulletin.pdf
     June 11, 2019 - fluids of a person infected with HIV, most commonly during sex without a condom or through injection drug … with a partner whose HIV status is unknown and who is at high risk for HIV, and sharing injection drug … candidates for PrEP, clinicians need to ask all patients about their sexual history and injection drug